
Results
2
2 companies
Kuros Biosciences
Market Cap: CHF 858.7m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 21.00
7D
-7.9%
1Y
-21.4%
Cosmo
Market Cap: CHF 1.4b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 82.30
7D
-12.0%
1Y
72.7%